serum institute of india news]
Latest from serum institute of india
Adar Poonawalla's statement came even as the UK became the first country to authorise an updated version of Moderna's Covid-19 vaccine that includes protection against the Omicron variant.
India has so far reported eight cases of monkeypox, of which five have been from Kerala and three from Delhi. Of the five patients in Kerala, one succumbed to the disease on July 30, making it India's first monkeypox fatality.
Published on Aug 02, 2022 05:41 PM IST
Written by Sharangee Dutta | Edited by Aniruddha Dhar, New Delhi
SII manufactures Covovax under a license from the vaccine’s developer, US-based Novavax. The export version of the vaccine is called Nuvaxovid and has been dispatched to New Zealand, Netherlands, Australia and Indonesia, where a total of at least 100 million doses have been sent.
Cervical cancer in India ranks as the second most frequent cancer among women between 15 and 44 years of age.
Published on Jun 15, 2022 10:37 PM IST
On April 29, the National Technical Advisory Group on Immunisation (NTAGI)--the government’s technical panel--recommended inclusion of Covovax in the vaccination programme for children aged 12 and above.
Serum Institute of India (SII) director for government and regulatory affairs Prakash Kumar Singh had written to the Centre recently requesting for Covovax's inclusion in the immunisation drive for children aged 12 to 17 years.
Speaking to ANI, Poonawalla said, "The Covid-19 vaccines which have been made in India are providing more protection against the disease than mRNA vaccines like Pfizer and Moderna."
Published on Apr 13, 2022 04:22 PM IST
Covovax - which has not been formally announced as a booster shot, will be priced around ₹900 plus taxes, once approved. The vaccine is currently being used to inoculate adults and those in the 12-17 age group in emergency situations.
Updated on Apr 08, 2022 06:54 PM IST
hindustantimes.com | Written by Sharangee Dutta, New Delhi
Submitting its reply to Puliyel’s petition in November last, the central drugs standard control organization (CDSCO) said that entertaining such a petition would harm public interest.
Serum Institute of India locally manufactures the Oxford-AstraZeneca Covid-19 vaccine under the brand name Covishield.
Serum Institute, which produces AstraZeneca's Covid-19 vaccine under the brand name Covishield, has supplied more than 1.25 billion doses of the shot in India.
Published on Dec 31, 2021 01:48 PM IST
Reuters | , Bengaluru
SII has the license to produce over two billion doses of the vaccine
The investment was made through the Indian company's Serum Life Sciences unit, Oxford University said on Wednesday.
Published on Dec 15, 2021 05:50 AM IST
The Pune-based SII had earlier on December 1 requested the DCGI to authorise Covishield as a booster dose, citing the emergence of new coronavirus variants in the country and an adequate stock of vaccines to tackle that growing concern.
Published on Dec 11, 2021 07:53 AM IST
Written by Joydeep Bose | Edited by Meenakshi Ray, Hindustan Times, New Delhi
In an application to DCGI, Prakash Kumar Singh, director of government and regulatory affairs at Serum Institute of India wrote that there is no shortage of Covishield in India now and the demand for booster dose is rising by each passing day in wake of the emerging new strains of the coronavirus.
Published on Dec 01, 2021 11:15 PM IST
Written by Sharangee Dutta | Edited by Amit Chaturvedi, Hindustan Times, New Delhi
India in March put a temporary hold on all major exports of the AstraZeneca shot made by the family-run firm to inoculate its citizens during a devastating surge in Covid-19 cases.
Published on Nov 26, 2021 06:24 PM IST
India halted export of Covid-19 vaccines in April after a severe second wave hit the country that impacted the Covid-19 vaccines global access, or Covax programme, which has been established to deliver Covid-19 vaccines equitably to all countries.
In April, the Centre halted supply of Covid-19 vaccines to the UN-backed programme as India itself was hit by a severe second wave of the pandemic.
Recently, Prakash Kumar Singh, Director, Government and Regulatory Affairs at SII, wrote to the DCGI seeking no objection certification to export 50 lakh vials of Covovax.
Published on Nov 15, 2021 11:17 PM IST
PTI | | Posted by Sharangee Dutta, Hindustan Times, New Delhi
This makes it the third Covid-19 vaccine to be tested in children in India, after Bharat Biotech’s Covaxin and Zydus Cadila’s ZyCoV-D.
The global alliance Gavi also said it is keen on collaborating with Serum Institute of India and the health ministry to protect vulnerable people from Covid-19 virus.
SII has been scaling up production by enhancing the manufacturing capacity of Covishield to more than 20 crore doses per month.
This is double the number of doses the SII earlier told central government it will deliver in September.
The Pune-based Serum Institute of India's CEO Adar Poonawalla said in a statement that securing supply chain is of "strategic importance."
Published on Aug 17, 2021 09:41 PM IST
ANI | | Posted by Sharangee Dutta, Hindustan Times, New Delhi
Here are today’s top news, analysis and opinion. Know all about the latest news and other news updates from Hindustan Times.
The drug controller responds even after office hours, Cyrus Poonawalla said praising PM Modi's reforms that ended licenceraj. Once he had to fall at the feet of the bureaucrats, the chairman of the world's largest vaccine maker said.
Here are today’s top news, analysis, and opinion. Know all about the latest news and other news updates from Hindustan Times.
The Serum Institute of India CEO also said that the price of the anti-Covid vaccine will be determined at the time of launch.
Published on Aug 06, 2021 06:53 PM IST
hindustantimes.com | Written by Karan Manral, New Delhi
Speaking on Friday’s development, SII’s chief executive officer (CEO) Adar Poonawalla said the partnership with the Confederation of Indian Industry “will be a good way to close the gaps” as there is plenty of supply of Covishield doses available for distribution.
Updated on Jul 30, 2021 06:00 PM IST
hindustantimes.com | Written by Harshit Sabarwal | Edited by Poulomi Ghosh, New Delhi